Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Current Assets (2021 - 2025)

Historic Current Assets for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $6.0 million.

  • Coeptis Therapeutics Holdings' Current Assets rose 33899.58% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 33899.58%. This contributed to the annual value of $1.1 million for FY2024, which is 3991.63% down from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Current Assets of $6.0 million as of Q3 2025, which was up 33899.58% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Current Assets registered a high of $6.9 million during Q1 2024, and its lowest value of $30967.0 during Q3 2022.
  • For the 5-year period, Coeptis Therapeutics Holdings' Current Assets averaged around $2.5 million, with its median value being $2.0 million (2021).
  • In the last 5 years, Coeptis Therapeutics Holdings' Current Assets crashed by 9486.71% in 2022 and then surged by 1320602.25% in 2023.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Current Assets (Quarter) stood at $2.2 million in 2021, then skyrocketed by 80.85% to $3.9 million in 2022, then tumbled by 55.61% to $1.7 million in 2023, then tumbled by 39.92% to $1.1 million in 2024, then skyrocketed by 469.86% to $6.0 million in 2025.
  • Its last three reported values are $6.0 million in Q3 2025, $3.7 million for Q2 2025, and $4.7 million during Q1 2025.